Kim Hong Jun, Jung Eun Hee, Kwon Jung Hye, Kim Yu Jung, Koh Su-Jin, Lee Myung Ah, Kang Jung Hun, Rha Sun Young, Nam Eun Mi, Baek Sun Kyung, Lee Ha Yeon, Song Hun Ho, Won Young-Woong, Lee Hanbyul
Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Korea.
Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Cancer Res Treat. 2025 Jul;57(3):891-898. doi: 10.4143/crt.2024.706. Epub 2024 Dec 5.
Identifying the palliative care needs of patients with advanced cancer is important for maintaining quality of life and timely transition to palliative care. We aimed to validate the Korean Sheffield Profile for Assessment and Referral for Care (K-SPARC) in such patients and establish its psychometric properties, including reliability, validity, and responsiveness to change.
We used the forward-back translated version of SPARC, which was verified through a pilot study, to assess the palliative care needs of patients with advanced cancer. Reliability was evaluated by internal consistency using Cronbach's alpha coefficients and test-retest reliability. Criterion validity was analyzed against other questionnaires, including the Korean versions of the Functional Assessment of Cancer Therapy-General (FACT-G Korean) and Korean versions of the Edmonton Symptom Assessment System (K-ESAS). Factor analysis was used to assess construct validity.
Two hundred fifty-nine patients were included from 2019 to 2022. Forty-nine percent of all patients were women, and the median age was 63 years. Cronbach's alpha coefficient (range, 0.642 to 0.903) and test-retest reliability (range, 0.574 to 0.749) indicated acceptable reliability. The correlation coefficients between K-SPARC and FACT-G Korean suggested significant criterion validity. The correlation coefficients for the physical, social, emotional, and functional domains were 0.701, 0.249, 0.718, and 0.511, respectively (p < 0.001, all). Factor analysis demonstrated satisfactory construct validity of the tool.
This study demonstrated the utility of K-SPARC as an evaluation tool for providing palliative care to patients with advanced cancer through psychometric validation; the tool had good internal consistency, reliability, and acceptable validity.
识别晚期癌症患者的姑息治疗需求对于维持生活质量和及时过渡到姑息治疗至关重要。我们旨在验证韩国版的谢菲尔德护理评估与转诊概况（K-SPARC）在这类患者中的有效性，并确定其心理测量学特性，包括可靠性、有效性和对变化的反应性。
我们使用了经预试验验证的SPARC前后翻译版本，以评估晚期癌症患者的姑息治疗需求。通过使用Cronbach's α系数的内部一致性和重测信度来评估可靠性。对照其他问卷分析效标效度，包括韩国版的癌症治疗功能评估通用版（FACT-G Korean）和韩国版的埃德蒙顿症状评估系统（K-ESAS）。采用因子分析来评估结构效度。
2019年至2022年共纳入259例患者。所有患者中49%为女性，中位年龄为63岁。Cronbach's α系数（范围为0.642至0.903）和重测信度（范围为0.574至0.749）表明可靠性可接受。K-SPARC与FACT-G Korean之间的相关系数表明具有显著的效标效度。身体、社会、情感和功能领域的相关系数分别为0.701、0.249、0.718和0.511（均p < 0.001）。因子分析表明该工具具有令人满意的结构效度。
本研究通过心理测量学验证证明了K-SPARC作为评估工具为晚期癌症患者提供姑息治疗的效用；该工具具有良好的内部一致性、可靠性和可接受的有效性。
